Cargando…
Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing.
Carcinogenicity testing is indispensable for identifying environmental carcinogens and for evaluating the safety of drugs in the process of development. Conventional 2-year rodent bioassays are one of the most resource-consuming tests in terms of animals, time, and costs. Development of rapid carcin...
Autores principales: | Yamamoto, S, Urano, K, Koizumi, H, Wakana, S, Hioki, K, Mitsumori, K, Kurokawa, Y, Hayashi, Y, Nomura, T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1533281/ https://www.ncbi.nlm.nih.gov/pubmed/9539005 |
Ejemplares similares
-
The Mouse rasH2/BHT Model as an in vivo Rapid Assay for Lung Carcinogens
por: Umemura, Takashi, et al.
Publicado: (2002) -
In vivo transgenic bioassays and assessment of the carcinogenic potential of pharmaceuticals.
por: Contrera, J F, et al.
Publicado: (1998) -
Evaluation and validation issues in the development of transgenic mouse carcinogenicity bioassays.
por: Tennant, R W
Publicado: (1998) -
Medium-term bioassays for carcinogenicity of chemical mixtures.
por: Ito, N, et al.
Publicado: (1998) -
Transgenic Rats Carrying Human c‐Ha‐ras Proto‐oncogene Are Highly Susceptible to N‐Nitrosomethylbenzylamine Induction of Esophageal Tumorigenesis
por: Asamoto, Makoto, et al.
Publicado: (2002)